OVERVIEW

This full-day symposium offers a comprehensive review of new diagnostic techniques and therapeutic treatments, the latest clinical trials, and state-of-the-art technology in contemporary cardiovascular medicine using concise didactic presentations, combined with a panel discussion and case presentations. Following this course, the participant should be able to formulate a practical approach to common cardiovascular disorders; identify the appropriate tests that can be used to determine the severity of the patient problem and make an accurate diagnosis; discuss the various treatment options available; and recognize how to treat and when to refer cardiac patients. This activity is expected to result in increased confidence in making a diagnosis and providing effective treatment, referral, and follow-up care with the overall goal of improving patient outcomes.

TARGET AUDIENCE

Family physicians, internists, cardiologists, cardiovascular thoracic surgeons, advance practice providers, nurses, allied health professionals, and other health care professionals who treat and care for patients with heart disease will benefit from attending this educational activity.

LEARNING OBJECTIVES

AT THE CONCLUSION OF THIS ACTIVITY, THE PARTICIPANT SHOULD BE ABLE TO:

• Review key perspectives of the 2023 guidelines for diagnosis and management of atrial fibrillation.

• Discuss new ablation technologies (PFA).

• Discuss stroke prevention with a focus on left atrial appendage closure (LAAC)

• Recognize the burden of Hypertension.

• Review the role of Renal Denervation in the treatment of hypertension.

• Recognize situations where a hypercoagulability workup is rarely indicated.

• Assess the need for long-term anticoagulation by evaluating the presence of cancer, thrombus, and provoked and unprovoked thrombotic events.

• Describe at least two tools for assessing cardiac risk in a primary prevention patient.

• Describe at least two non-statin medications to address cardiac risk.

• Review interesting cases and cutting-edge treatments in cardiovascular medicine.

• Discuss the pathophysiology and management principles of congenital heart disease.

• Recognize congenital conditions that can present for the first time in adulthood.

• Recognize the common sequelae of congenital heart disease that was repaired in childhood.

• Evaluate the decision-making pathway for managing a STEMI patient from First Medical Contact (FMC) to the initiation of Percutaneous Coronary Intervention (PCI) from the emergency department perspective.

• Assess the decision-making pathway for managing a STEMI patient from First Medical Contact (FMC) to the initiation of Percutaneous Coronary Intervention (PCI) from the interventional cardiology perspective.

• Review the top 5 cardiology articles of the past year.

ACCREDITATION

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.